ArticleMolecular diagnosis & therapy2026

Bridging Biomarker Testing to Biomarker-Driven Targeted Therapy: Real-World ESR1 Mutation Testing Patterns and Prevalence in ER+, HER2- Metastatic Breast Cancer.

Chi-Yin Liao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.